SEC Comment Letter for ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Jan 9, 2012
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: Jan. 9, 2012 · CIK: 0001174940 · Accession: 0000000000-12-001152
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-32188
Letter
January 9, 2012 Via E-mail Brian J. Bohunicky Chief Financial Officer Oragenics, Inc. 3000 Bayport Drive, Suite 685 Tampa, FL 33607 Re: Oragenics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 30, 2011 File No. 001-32188
Dear Mr. Bohunicky: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Bryan J. Pitko for Jeffrey Riedler
Assistant Director
Show Raw Text
January 9, 2012 Via E-mail Brian J. Bohunicky Chief Financial Officer Oragenics, Inc. 3000 Bayport Drive, Suite 685 Tampa, FL 33607 Re: Oragenics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 30, 2011 File No. 001-32188 Dear Mr. Bohunicky: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Bryan J. Pitko for Jeffrey Riedler Assistant Director